# Arrail Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arrail-group

- Industry: Healthcare Specialists
- Headquarters: Beijing, China
- Website: www.arrail-dental.com
- Total disclosed funding: $400M
- Latest round: Series E (Apr 13, 2021)
- Investors on record: 14

## About

Based in Beijing, China, and established in 1999, Arrail Group Limited previous known as Arrail Dental International Group Co. Ltd, is a medical company that focuses on the dental field. The company has two brands, including Arrail Dental, and Rytime Dental. The company has 111 directly operation dental hospitals and clinics, 882 dental doctors, 1,300 dental chairs. Also, the company's business covered 15 cities, including Beijing, Shanghai, Shenzhen, Chongqing. As of September 2021, the company served 7.40 million passengers, and the follow-up rate was 47.6%. In March 2022, the company was listed on Hongkong Stock Exchange under the number 06639. 

The company provides dental medical services. Specific services include general dentistry, orthodontics teethes, and implantology teethes. General dentistry provides scaling, dental disease examination and screening, fillings teethes, root canal treatment and restoration of missing teeth. The orthodontics teethes provide treatment for occlusal malocclusion that may be caused by abnormal jaw proportions. The implantology teethes provide permanent implantation of artificial teethes in the jawbone when the natural teethes must be extracted. Those services can be divided into high-end dental care services,  mid-range dental care services, and economic
dental care services. 

The company plans to expand the business, and open over 10 dental hospitals and clinics every year in China.

## Funding rounds

- Series E, Apr 13, 2021, $200M — OrbiMed Advisors, Temasek Holdings, Hina Group, WFM Asia, China Industrial Bank, Mirae Asset Financial Group
- Series D, Aug 29, 2017, $90M — Goldman Sachs Asset Management, Hillhouse Investment
- Series C, Apr 22, 2014, $70M — Kleiner Perkins, CF Private Equity, Qiming Venture Partners, New Horizon Capital, GL Capital Group, Prometheus Capital
- Series B, Aug 1, 2011, $20M — Kleiner Perkins, Qiming Venture Partners, GL Capital Group
- Series A, May 25, 2010, $20M — Kleiner Perkins, Qiming Venture Partners

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B, Series C
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B, Series C
- GL Capital Group (https://capitalatlas.ai/funds/gl-capital-group) — Series B, Series C
- CF Private Equity (https://capitalatlas.ai/funds/cf-private-equity) — Series C
- New Horizon Capital — Series C
- Prometheus Capital (https://capitalatlas.ai/funds/prometheus-capital) — Series C
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series D
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series D
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series E
- Temasek Holdings — Series E
- Hina Group (https://capitalatlas.ai/funds/hina-group) — Series E
- WFM Asia — Series E
- China Industrial Bank — Series E
- Mirae Asset Financial Group — Series E